(Portland, Ore.) – Dennis McNannay, executive director of the Oregon Bioscience Association, has been appointed to the board of directors of the national Council of State Bioscience Associations for the 2015-2016 term.

The CSBA is an autonomous council of state-based biotechnology associations operating within BIO, the Biotechnology Industry Organization. CSBA serves as a link to thousands of bioscience companies throughout the United States. According to BIO’s most recent benchmarking report, Oregon is home to 802 bioscience establishments.

“This is a fantastic opportunity to grow awareness around the strengths and successes of Oregon’s life sciences and biotechnology industry, especially the well-recognized workforce training and the rise in research and development for both new devices and new medicines,” said McNannay.

Other members of the CSBA executive committee and board of directors include executives from New York, Texas, Georgia, Colorado, Delaware and Indiana.

# # #

The Oregon Bioscience Association advocates for its members and the industry to create opportunity through community, collaboration and commercialization.  Oregon Bio promotes the growth and quality of the bioscience industry in Oregon and continually seeks ways to support sustainability and growth in the life science, bioscience, biotechnology and device manufacturing industries and to create acceleration initiatives so members can achieve their full scientific, economic and social potential. Oregon Bio, a nonprofit membership association, is the Oregon affiliate of BIO, Biotechnology Industry Organization.

BIO found in 2014 Oregon’s jobs in biotech grew faster than most other U.S. markets. The association’s most current economic impact study showed that Oregon has 802 bioscience establishments and 13 life science research institutions and that Oregon is emerging in several bioscience areas with job growth in four of the five major subsectors from 2007 to 2012. BIO also found  the state’s research, testing, and medical labs subsector has grown particularly fast in recent years, increasing employment by 33 percent. Oregon’s research universities are especially focused in the biosciences relative to other fields with their $456 million in bioscience academic R&D in 2012 accounting for 67 percent of all academic research.

NIH awarded Oregon nearly $304 million in 2014, with 673 grants awarded to 42 firms. Additionally, the National Cancer Institute gave 62 awards, totaling more than $39 million; 43 SBIR and STTR awards totaled $18.8 million; the Department of Defense granted almost $3 million; and the National Science Foundation awarded $60.3 million in grants. More about the Oregon Bioscience Association can be found at www.oregonbio.org.

CONTACT: Dennis McNannay, executive director, Oregon Bio, 503-548-4432
Dianne Danowski Smith, Oregon Bio Board member, 503-201-7019; @OregonBio